Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Advanced Non-Small Cell Lung Cancer Clinical Trials

3 recruiting trials for Advanced Non-Small Cell Lung Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
2
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT06043973

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

To evaluate the efficacy and safety of almonertinib plus anlotinib as first-line treatment for advanced non-small cell lung cancer with EGFR sensitive mutation and TP53 mutation....

Sponsor: Qianfoshan HospitalEnrolling: 981 location
RECRUITINGPhase 3NCT07222566

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants...

This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with...

Sponsor: PfizerEnrolling: 141017 locations
RECRUITINGPhase 1NCT07090499

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

The purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck,...

Sponsor: PfizerEnrolling: 31020 locations